Skip to main content
For laboratory research use only. Not for human or veterinary use.
Free shipping on every order
10% off your first order · code FIRST10
GLP-1 familyCompanion animal

Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus

Scuderi MA, Ribeiro Petito M, Unniappan S, et al. · Domest Anim Endocrinol · 2018
PMID: 30015124 · DOI: 10.1016/j.domaniend.2018.04.003
Summary

Veterinary study evaluating combined GLP-1 mimetic and insulin glargine in client-owned diabetic cats. Endpoints: glycemic control, insulin requirement, adverse events across treatment period.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

Compounds referenced in this study
  • GLP-1 S
    Single-receptor incretin class agonist studied in incretin-pathway metabolic research.
    View product →
Guides covering this compound
More GLP-1 family citations
Browse the catalog